trial · primary record
Fluoxetine 20 mg
Depressive Disorder
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 75 |
| Primary completion | 2023-12-20 |
| Primary endpoint | • The primary endpoint is the change in Hamilton Rating Scale |
| Registry ID | NCT05792540 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:38.454Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05792540
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.